Recombinant Human CCDC6 Protein, N-His-SUMO

Description of Recombinant Human CCDC6 Protein, N-His-SUMO

Introduction

Recombinant Human CCDC6 Protein, also known as Coiled-Coil Domain Containing 6 protein, is a human protein that plays a crucial role in various cellular processes. It is encoded by the CCDC6 gene and is a member of the coiled-coil domain family of proteins. Recombinant Human CCDC6 Protein has been extensively studied and has been found to have important structural and functional properties that make it a valuable tool in scientific research and potential therapeutic applications. In this article, we will discuss the structure, activity and applications of this protein in detail.

Structure of Recombinant Human CCDC6 Protein

Recombinant Human CCDC6 Protein is a 65 kDa protein that consists of 572 amino acids. It has a coiled-coil domain at its N-terminus, which is responsible for its structural stability and interaction with other proteins. The coiled-coil domain is a structural motif that consists of two or more alpha-helices coiled around each other. This domain is essential for the protein’s function as it allows it to form stable interactions with other proteins and play a role in various cellular processes.

At its C-terminus, Recombinant Human CCDC6 Protein has a proline-rich domain, which is involved in protein-protein interactions and is important for its activity. This domain has been found to interact with several other proteins, including transcription factors and signaling molecules, suggesting its role in various signaling pathways.

Activity of Recombinant Human CCDC6 Protein

Recombinant Human CCDC6 Protein has been found to have multiple activities in various cellular processes. It has been shown to play a role in cell cycle regulation, DNA damage response, and apoptosis. It has also been found to be involved in transcriptional regulation and protein translation.

One of the key activities of Recombinant Human CCDC6 Protein is its role in cell cycle regulation. It has been found to regulate the G1 to S phase transition by interacting with cyclin D1 and CDK4, two proteins involved in cell cycle progression. This interaction inhibits the activity of CDK4, thereby preventing cell cycle progression and promoting cell cycle arrest.

In addition to its role in cell cycle regulation, Recombinant Human CCDC6 Protein also plays a crucial role in the DNA damage response. It has been found to interact with and regulate the activity of several proteins involved in DNA repair, such as BRCA1 and RAD51. This suggests its role in maintaining genomic stability and preventing the development of cancer.

Applications of Recombinant Human CCDC6 Protein

Recombinant Human CCDC6 Protein has a wide range of potential applications in scientific research and potential therapeutic interventions. Its involvement in various cellular processes makes it a valuable tool for studying the mechanisms of cell cycle regulation, DNA damage response, and cancer development.

One potential application of Recombinant Human CCDC6 Protein is in cancer treatment. Its role in the DNA damage response and interaction with proteins involved in DNA repair make it a potential target for cancer therapy. Inhibiting the activity of Recombinant Human CCDC6 Protein could sensitize cancer cells to DNA-damaging agents, making them more susceptible to treatment.

Furthermore, Recombinant Human CCDC6 Protein could also be used as an antigen in the development of diagnostic tests for certain cancers. It has been found to be overexpressed in several types of cancer, including thyroid cancer and acute myeloid leukemia. Thus, using Recombinant Human CCDC6 Protein as an antigen in diagnostic tests could aid in the early detection and diagnosis of these cancers.

Conclusion

In conclusion, Recombinant Human CCDC6 Protein is a crucial protein with important structural and functional properties. Its role in cell cycle regulation, DNA damage response, and potential applications in cancer research make it a valuable tool in scientific research and a potential target for therapeutic interventions. Further studies on this protein